PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35278900-0	2022	Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-kappaB-mediated signaling pathway.	tubeimoside I	0-13	nuclear factor kappa B subunit 1	Homo sapiens	154-163	
22005259-0	2011	NF-kappaB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G2/M cell cycle arrest.	tubeimoside I	48-61	nuclear factor kappa B subunit 1	Homo sapiens	0-9	
22005259-8	2011	Moreover, tubeimoside-1 induced accumulation of reactive oxygen species and arrested cell cycle at the G(2)/M phase, thus contributing to apoptosis, through signaling regulation by tumor necrosis factor alpha, nuclear factor kappaB (NF-kappaB), Jun N-terminal kinase (JNK) and p53.	tubeimoside I	10-23	nuclear factor kappa B subunit 1	Homo sapiens	225-231	
22005259-8	2011	Moreover, tubeimoside-1 induced accumulation of reactive oxygen species and arrested cell cycle at the G(2)/M phase, thus contributing to apoptosis, through signaling regulation by tumor necrosis factor alpha, nuclear factor kappaB (NF-kappaB), Jun N-terminal kinase (JNK) and p53.	tubeimoside I	10-23	nuclear factor kappa B subunit 1	Homo sapiens	233-242